Corgenix Medical Corp. (CONX.OB) Awarded FDA Clearance for Testing Kit
Corgenix Medical Corp. (OTCBB: CONX) today announced it received 510(k) clearance from the U.S. Food and Drug Administration for its IgG Anti-AtherOx Test Kit used to detect antibodies in individuals with autoimmune diseases. Research data shows the association of antibodies to the AtherOx complex with vascular thrombosis in patients with autoimmune diseases. According to the press release, the clearance will allow for the new laboratory test to be marketed on a global scale. "We are pleased to receive FDA clearance for this important product. Corgenix has a long history of developing and bringing to market innovative products for rheumatology and…